Skip to main content

Cabot Corp

corporate_fare Company Profile

Cabot Corp

CBT·NYSE·Industrial Applications And Services·CIK 0000016040

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company, founded in 1882 and incorporated in Delaware in 1960, manufactures principal products including reinforcing and specialty carbons, specialty compounds, conductive additives, carbon nanotubes, fumed metal oxides, inkjet colorants, and aerogel. Cabot and its affiliates operate manufacturing facilities and operations in the United States and over 20 other countries. The company's products are based on technical expertise and innovation in four core competencies: making and handling very fine particles; modifying the surfaces of very fine particles to alter their functionality; designing particles to impart specific properties to a formulation; and combining particles with other ingredients to deliver a formulated performance intermediate or composite. Cabot focuses on creating particles and formulations with specific composition, morphology, and surface functionalities to support customer applications. The business is organized into two reportable segments: Reinforcement Materials and Performance Chemicals.

Cabot Corp (NYSE:CBT) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 14 items for CBT at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-28, rated 7/10. Across its 14 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above. Recent SEC coverage for CBT spans 144, 10-Q, 8-K.

Recent high-impact activity:

  • Outgoing CEO Keohane Files to Sell Another $11.5M in Cabot Shares
  • Retiring CEO Sean Keohane Files to Sell $7.94M in Shares
  • Restructuring and Pension Charges Drive Cabot's Q3 Earnings Plunge
  • Cabot Q3 EPS Beats by a Penny, Revenue Up 6%; CEO Transition Set
  • Cabot Q3 Adjusted EPS of $1.67 Beats Consensus; FY26 Guidance Tightened to $6.15–$6.45

Financial Snapshot

Fiscal year ended September 30, 2025
Revenue
$3.71B
Net Income
$331M
Diluted EPS
$6.02
Op. Cash Flow
$665M
Free Cash Flow
$391M
Gross Profit
$940M
Operating Income
$621M
Cash & Equivalents
$258M
Total Debt
$1.12B
Debt / Equity
0.72×
Net Margin
8.9%
Shares Outstanding
52.84M sh
Source: 10-K · filed 2025-11-24 · accession 0001193125-25-292412

Dilution Risk

Low risk

Filing-implied dilution signals for CBT, detected from its recent SEC filings · based on capital-structure filings through 2026-08-12.

1 recent capital raise

Debt Offering Priced · Investment-Grade Ratings

⚠ A more recent filing has been published for this ticker since this signal was computed; it may not yet be reflected — see the filings below.

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with C →
$78.87 -0.81% today
52-week range · as of 2026-08-28 $58.33 – $94.53
Market cap
$4.07B
Volume
118.3K (0.3× avg)
3-mo avg 409.8K
Live data · 2026-09-14 18:35 UTC · Market open

show_chartPrice Chart

Loading chart...

feed CBT - Latest Insights

CBT
Aug 28, 2026, 10:21 AM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $84.43
Real-time Price: $78.87 info
Change: -$5.55 (-7%) info
Market Cap: $4.072B info
CBT
Aug 07, 2026, 3:19 PM EDT
Filing Type: 144
Importance Score:
7
Price at Filing: $87.38
Real-time Price: $78.87 info
Change: -$8.51 (-10%) info
Market Cap: $4.072B info
CBT
Aug 04, 2026, 2:58 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $81.20
Real-time Price: $78.87 info
Change: -$2.33 (-3%) info
Market Cap: $4.072B info
CBT
Aug 03, 2026, 4:52 PM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $89.58
Real-time Price: $78.87 info
Change: -$10.71 (-12%) info
Market Cap: $4.072B info
CBT
Aug 03, 2026, 4:39 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.83
Real-time Price: $78.87 info
Change: -$0.960 (-1%) info
Market Cap: $4.072B info
CBT
Aug 03, 2026, 4:36 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $89.58
Real-time Price: $78.87 info
Change: -$10.71 (-12%) info
Market Cap: $4.072B info
CBT
Jul 30, 2026, 8:35 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $91.43
Real-time Price: $78.87 info
Change: -$12.56 (-14%) info
Market Cap: $4.072B info
CBT
May 14, 2026, 8:00 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $82.90
Real-time Price: $78.87 info
Change: -$4.03 (-5%) info
Market Cap: $4.072B info
CBT
May 06, 2026, 4:23 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $82.41
Real-time Price: $78.87 info
Change: -$3.54 (-4%) info
Market Cap: $4.072B info
CBT
May 05, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $79.66
Real-time Price: $78.87 info
Change: -$0.790 (-0.99%) info
Market Cap: $4.072B info
CBT
May 05, 2026, 4:30 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $78.93
Real-time Price: $78.87 info
Change: -$0.060 (-0.08%) info
Market Cap: $4.072B info
CBT
May 04, 2026, 7:16 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $75.85
Real-time Price: $78.87 info
Change: +$3.02 (+4%) info
Market Cap: $4.072B info
CBT
Feb 04, 2026, 1:36 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $78.93
Real-time Price: $78.87 info
Change: -$0.060 (-0.08%) info
Market Cap: $4.072B info
CBT
Feb 03, 2026, 4:40 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $71.20
Real-time Price: $78.87 info
Change: +$7.67 (+11%) info
Market Cap: $4.072B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets